Extracorporeal shockwave therapy (ESWT) for refractory Achilles tendinopathy: A prospective audit with 2-year follow up

The Foot
James TaylorPaul Guyver

Abstract

Achilles tendinopathy (AT) represents a triad of tendon pain, swelling and impaired performance. Extracorporeal shockwave therapy (ESWT) has been endorsed by the National Institute for Health and Care Excellence (NICE) for refractory AT. This audit investigates the long-term outcomes of patients treated with ESWT for refractory AT. Forty-six patients treated with ESWT for AT between October 2010 and August 2011 completed visual analogue, satisfaction scores and functional assessment questionnaires over two years. Patients were subdivided into two groups depending on whether their AT was insertional (IAT) or non-insertional (NAT). Forty-six patients (mean age 58 years) completed all treatments and full 2 year follow up. There was significant improvement in pain at rest, on activity and of function within both NAT and IAT groups over the two-year period. Satisfaction scores were significant in the NAT group but not in the IAT group. ESWT appears to be of benefit in the long term improvement of pain at rest, on activity and functional outcome in patients with refractory AT. However, subjective patient opinion may not match the perceived clinical outcome observed in this audit in all patients and individuals should be counselled re...Continue Reading

References

Jun 1, 1988·British Journal of Sports Medicine·D J DaCruzI Phair
Jun 10, 1998·The Journal of Bone and Joint Surgery. British Volume·J D RompeO Krischek
Dec 16, 1998·Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association·N MaffulliG Puddu
Jun 11, 2002·British Journal of Sports Medicine·Mika PaavolaM Järvinen
Jul 30, 2002·British Journal of Sports Medicine·D KaderN Maffulli
Jun 13, 2003·International Orthopaedics·Maria Chiara VulpianiAndrea Ferretti
Aug 23, 2008·British Journal of Sports Medicine·M T van LeeuwenI van den Akker-Scheek
Jan 12, 2011·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·C N van DijkN Maffulli
Mar 22, 2012·Journal of Orthopaedic Surgery and Research·Ching-Jen Wang
Oct 12, 2012·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·J I WiegerinckC N van Dijk
Mar 3, 2015·Clinics in Orthopedic Surgery·Roberto Gabriel L Lopez, Hong-Geun Jung

❮ Previous
Next ❯

Citations

Dec 15, 2010·Sports Medicine, Arthroscopy, Rehabilitation, Therapy & Technology : SMARTT·Sai-Chuen FuKai-Ming Chan
Nov 15, 2017·Current Sports Medicine Reports·Majid AnsariMorteza Khodaee
May 2, 2018·The Journal of Orthopaedic and Sports Physical Therapy·Robroy L MartinChristopher R Carcia
Oct 6, 2017·Der Unfallchirurg·S F BaumbachH Polzer
May 22, 2018·Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine·Patrick C Wheeler, Chloe Tattersall
Jan 18, 2020·BioMed Research International·Magdalena StaniaPiotr Król
Aug 10, 2017·Foot & Ankle International·Ruth L ChimentiPhinit Phisitkul
Jan 26, 2017·Der Unfallchirurg·Ralph Gaulke, Christian Krettek
Sep 25, 2020·PM & R : the Journal of Injury, Function, and Rehabilitation·Adam TenfordeJaspal Ricky Singh
Jul 22, 2019·Journal of Functional Morphology and Kinesiology·Vito PavoneGianluca Testa
May 25, 2021·The Journal of Bone and Joint Surgery. American Volume·Nacime Salomão Barbachan MansurMarcel Jun Sugawara Tamaoki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.